FMP

FMP

Emerson Electric Co. (NYSE: EMR) Sees Positive Analyst Adjustment and Surge in Options Trading

  • KeyBanc upgrades Emerson Electric Co. (NYSE: EMR) to "Overweight" and raises price target from $155 to $185.
  • Emerson experiences a significant increase in options trading activity, with a 95% jump in call options.
  • CEO Surendralal Lanca Karsanbhai sells 7,263 shares, while company insiders own 0.23% of Emerson's stock.

Emerson Electric Co. (NYSE: EMR) is a global technology and engineering company that provides innovative solutions for customers in industrial, commercial, and residential markets. On February 5, 2026, KeyBanc adjusted its rating for Emerson to "Overweight," maintaining its previous grade. At the time, the stock was priced at $157.32. KeyBanc also raised Emerson's price target from $155 to $185, as highlighted by TheFly.

The stock's current price of $157.32 reflects a 3.43% increase, or $5.22, from its previous value. Today, EMR has fluctuated between $154.40 and $160.11. Over the past year, the stock has seen a high of $160.13 and a low of $90.06. Emerson's market capitalization stands at approximately $88.46 billion, indicating its significant presence in the market.

Emerson has experienced an unusual surge in options trading activity, with investors purchasing 3,480 call options, marking a 95% increase compared to the typical volume of 1,789 call options. This heightened activity suggests increased investor interest and confidence in the company's future performance, possibly influenced by KeyBanc's revised price target.

In related news, CEO Surendralal Lanca Karsanbhai sold 7,263 shares of Emerson stock at an average price of $133 per share, totaling approximately $966,000. Following this transaction, Karsanbhai's direct ownership stands at 196,292 shares, valued at around $26.1 million, reflecting a 3.57% decrease in his position. This sale was disclosed in a document filed with the Securities and Exchange Commission.

Company insiders currently own 0.23% of Emerson's stock. Additionally, institutional investors and hedge funds have been adjusting their stakes in the company. Today's trading volume for EMR is 9,699,161 shares, indicating active trading and interest in the stock.